Latest Lead News

BOA Resources advances drilling plans for key lithium and nickel tenements in Western Australia despite delays in heritage and environmental approvals, while actively reviewing its asset portfolio amid IGO's exit from Symons Hill.

Larvotto Resources delivers a robust Definitive Feasibility Study for its Hillgrove Antimony-Gold Project, backed by $165 million in fresh funding and regulatory approvals, targeting production in Q2 2026.

AVADA Group Limited reported a strong quarter with positive operating cash flows and significant debt reduction, while initiating a strategic review of its New Zealand operations amid challenging market conditions.

RocketBoots Limited has expanded its sales pipeline with five new customers covering over 8,550 locations and secured a strategic $1 million investment from Bombora Funds, positioning itself strongly in the growing AI retail technology market.

Wellnex Life Limited reported a robust Q4 FY25 with a 22% sales increase and positive operational cash flow, underpinning its strategic growth initiatives backed by new debt funding.

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

Ausmon Resources reports promising assay results from recent drilling programs targeting rare earth elements in South Australia and base metals near Broken Hill, NSW, setting the stage for expanded exploration.

PPK Group has dismissed any undisclosed information behind its recent share price surge, revealing instead that acquisition talks over its Craig International Ballistics stake have been terminated.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Oakridge International reported robust revenue growth and expanded its partner network in Q4 2025, underpinning a promising outlook in healthcare technology. The company also advanced product innovation aligned with new industry standards.